Literature DB >> 15647640

Intracellular cytokine expression in peritoneal monocyte/macrophages obtained from patients with cirrhosis and presence of bacterial DNA.

Rubén Francés1, Enrique Rodríguez, Carlos Muñoz, Pedro Zapater, Ma Luz De la, Moises Ndongo, Miguel Pérez-Mateo, José Such.   

Abstract

BACKGROUND: The detection of bacterial DNA in serum and ascitic fluid from patients with cirrhosis and ascites is interpreted as molecular evidence of intestinal bacterial translocation and considered sufficient to activate the cellular immune response. In vitro studies on ascitic fluid culture have shown a close relationship between the synthesis of several cytokines and nitric oxide and the presence of bacterial DNA. Since different cell types give rise to cytokines, flow cytometry becomes a powerful tool to discriminate between populations involved in a bacterial challenge.
OBJECTIVE: To study the pre-activation status of macrophage/monocyte population ex vivo according to the presence of bacterial DNA. PATIENTS: Patients with cirrhosis and culture-negative, non-neutrocytic ascites, with or without the presence of bacterial DNA in blood and ascitic fluid were studied.
METHODS: Flow cytometry analysis of intracellular cytokine expression in monocyte/macrophages from ascitic fluid was performed in basal conditions and after 12 h of cell stimulation adding lypopolysaccharide.
RESULTS: Monocyte/macrophages from patients with bacterial DNA showed a significantly higher production of interleukin-6 and tumor necrosis factor alpha in basal conditions than that in cells from patients without the presence of bacterial DNA. The addition of lipopolysaccharide produced a non-significant increment in the expression of these cytokines in patients with the presence of bacterial DNA, while this increment became significant in the other group of patients.
CONCLUSIONS: Bacterial translocation in patients with cirrhosis and ascites increases the basal intracellular cytokine expression, reducing its functional reserve capability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15647640     DOI: 10.1097/00042737-200501000-00010

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  11 in total

1.  Bacterial DNA induces a proinflammatory immune response in patients with decompensated cirrhosis.

Authors:  J Such; C Muñoz; P Zapater; M Pérez-Mateo
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

2.  Endoscopic characterization of the small bowel in patients with portal hypertension evaluated by double balloon endoscopy.

Authors:  Mayumi Kodama; Hirofumi Uto; Masatsugu Numata; Takeshi Hori; Takanobu Murayama; Fumisato Sasaki; Naoko Tsubouchi; Akio Ido; Kazuya Shimoda; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2008-08-17       Impact factor: 7.527

Review 3.  Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic Targeting.

Authors:  Arjuna Singanayagam; Evangelos Triantafyllou
Journal:  Front Immunol       Date:  2021-04-02       Impact factor: 7.561

4.  Cytokine production in patients with cirrhosis and TLR4 polymorphisms.

Authors:  Juan Camilo Nieto; Elisabet Sánchez; Eva Román; Silvia Vidal; Laia Oliva; Carlos Guarner-Argente; Maria Poca; Xavier Torras; Cándido Juárez; Carlos Guarner; German Soriano
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

5.  Translocation of bacterial DNA from Gram-positive microorganisms is associated with a species-specific inflammatory response in serum and ascitic fluid of patients with cirrhosis.

Authors:  R Francés; J M González-Navajas; P Zapater; C Muñoz; R Caño; S Pascual; F Santana; D Márquez; M Pérez-Mateo; J Such
Journal:  Clin Exp Immunol       Date:  2007-09-05       Impact factor: 4.330

Review 6.  Inflammatory status in human hepatic cirrhosis.

Authors:  María Martínez-Esparza; María Tristán-Manzano; Antonio J Ruiz-Alcaraz; Pilar García-Peñarrubia
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

7.  Blood Microbiome Quantity and the Hyperdynamic Circulation in Decompensated Cirrhotic Patients.

Authors:  Daniela Traykova; Beacher Schneider; Mario Chojkier; Martina Buck
Journal:  PLoS One       Date:  2017-02-01       Impact factor: 3.240

8.  Effects of symbiotic and vitamin E supplementation on blood pressure, nitric oxide and inflammatory factors in non-alcoholic fatty liver disease.

Authors:  Golnaz Ekhlasi; Mitra Zarrati; Shahram Agah; Agha Fatemeh Hosseini; Sharieh Hosseini; Shahrzad Shidfar; Seyed Soroush Soltani Aarbshahi; Elham Razmpoosh; Farzad Shidfar
Journal:  EXCLI J       Date:  2017-03-20       Impact factor: 4.068

9.  Human Amnion-Derived Mesenchymal Stromal Cells in Cirrhotic Patients with Refractory Ascites: A Possible Anti-Inflammatory Therapy for Preventing Spontaneous Bacterial Peritonitis.

Authors:  Mariangela Pampalone; Simona Corrao; Giandomenico Amico; Giampiero Vitale; Rossella Alduino; Pier Giulio Conaldi; Giada Pietrosi
Journal:  Stem Cell Rev Rep       Date:  2021-01-03       Impact factor: 5.739

10.  Probiotic as a novel treatment strategy against liver disease.

Authors:  Abbas Ali Imani Fooladi; Hamideh Mahmoodzadeh Hosseini; Mohammad Reza Nourani; Soghra Khani; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2013-02-25       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.